Related references
Note: Only part of the references are listed.Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S. J. Patterson et al.
GUT (2011)
Chronic hepatitis B in Asia-new insights from the past decade
Henry Lik-Yuen Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern
J. Inoue et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
Yanni Yan-Ni Lui et al.
ANTIVIRAL THERAPY (2010)
Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
Gloria Woo et al.
GASTROENTEROLOGY (2010)
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
Thomas Berg et al.
GASTROENTEROLOGY (2010)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: A 4-year study
Themistoklis G. Vassiliadis et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements
Geoffrey C. Farrell et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
M. H. Nguyen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
En-Qiang Chen et al.
VIROLOGY JOURNAL (2009)
Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis
D. L. Veenstra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound
Nadia Warner et al.
HEPATOLOGY (2008)
Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
Satoshi Shakado et al.
HEPATOLOGY INTERNATIONAL (2008)
The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B
Edward J. Gane
HEPATOLOGY INTERNATIONAL (2008)
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure
Stephen Locarnini
HEPATOLOGY INTERNATIONAL (2008)
High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma
Henry Lik-Yuen Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
Jessica Tan et al.
JOURNAL OF HEPATOLOGY (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B
H. L. -Y. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
Irene Rapti et al.
HEPATOLOGY (2007)
Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection
B. Ni Laoi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Hepatocellular carcinoma and hepatitis B virus
HLY Chan et al.
SEMINARS IN LIVER DISEASE (2006)
Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome
S Manolakopoulos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir
M Hussain et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
M Buti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
Yoon-Seon Lee et al.
HEPATOLOGY (2006)
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
P Lampertico et al.
HEPATOLOGY (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine-resistant mutants
VWS Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
MG Peters et al.
GASTROENTEROLOGY (2004)
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
HLY Chan et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Chronic hepatitis B virus infection in Asian countries
I Merican et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy
CT Yeh et al.
HEPATOLOGY (2000)
High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system
KR Loeb et al.
HEPATOLOGY (2000)
Share Paper
